| 45.87 Data as of Jun 18 | +0.21 / +0.46%Today’s Change | 30.25 Today|||52-Week Range 47.45 | +26.92% Year-to-Date |
| BSX Commences U.S. INTREPID Trial - Analyst Blog Jun 18 / Zacks.com | Health Services Stocks On The Rise With Help From 4 Stocks Jun 12 / TheStreet.com |
Hackers' next target: Your pacemakerJun 17 / CNNMoney.com | FDA Approves 2 St. Jude Heart Devices Jun 12 / MotleyFool.com |
Hackers' next target: Your pacemakerJun 17 / CNNMoney.com | Is This Fallen Angel Still a Good Growth Play? Jun 11 / MotleyFool.com |
| St Jude Medical Inc. Stock Buy Recommendation Reiterated (STJ) Jun 14 / TheStreet.com | St. Jude Expands Neuro Offerings - Analyst Blog Jun 10 / Zacks.com |
| FDA Nod for STJ's Ellipse & Assura - Analyst Blog Jun 13 / Zacks.com | GB Aims at Growth, Realigns Biz - Analyst Blog Jun 07 / Zacks.com |
| Today's 3 Best Stocks Jun 12 / MotleyFool.com | STJ Begins U.S. Trial for EnligHTN - Analyst Blog Jun 05 / Zacks.com |
| St Jude Medical Inc. (STJ): Today's Featured Health Services Winner Jun 12 / TheStreet.com |